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Abstract: Solar ultraviolet (UV) radiation is an important environmental factor that leads 
to immune suppression, inflammation, photoaging, and skin carcinogenesis. Here, we 
reviewed the specific signal transduction pathways and transcription factors involved in the 
cellular response to UV-irradiation. Increasing experimental data supporting a role for p38, 
MAPK, JNK, ERK1/2, and ATM kinases in the response network to UV exposure is 
discussed. We also reviewed the participation of NF-κB, AP-1, and NRF2 transcription 
factors in the control of gene expression after UV-irradiation. In addition, we discussed the 
promising chemotherapeutic intervention of transcription factors signaling by natural 
OPEN ACCESSInt. J. Mol. Sci. 2012, 13 143 
 
 
compounds. Finally, we focused on the review of data emerging from the use of DNA 
microarray technology to determine changes in global gene expression in keratinocytes and 
melanocytes in response to UV treatment. Efforts to obtain a comprehensive portrait of the 
transcriptional events regulating photodamage of intact human epidermis after UV 
exposure reveals the existence of novel factors participating in UV-induced cell death. 
Progress in understanding the multitude of mechanisms induced by UV-irradiation could 
lead to the potential use of protein kinases and novel proteins as specific targets for the 
prevention and control of skin cancer. 
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1. Introduction 
Ultraviolet radiation from sunlight is an environmental factor that has a variety of physiological and 
biological effects, including immune suppression, cellular aging, DNA damage and initiation of 
apoptosis [1,2]. In addition, UV radiation promotes the generation of reactive oxygen species (ROS) 
that can cause oxidative damage, and ultimately lead to tumor formation. Solar UV radiation is also a 
very prominent environmental toxic agent and it is known to be one of the main causes of human skin 
cancers, such as cutaneous, malignant melanomas and non-melanoma tumors that include basal cell 
carcinomas and squamous cell carcinomas [3,4]. UV is classified in three bands according to 
wavelength: UV-A (320–400 nm), UV-B (290–320 nm) and UV-C (<290 nm). UV-A is also Int. J. Mol. Sci. 2012, 13 144 
 
 
subclassified into UV-A1 (340–400 nm) and UV-A2 (320–340 nm). The UV component of the 
sunlight reaching the earth surface (daylight UV) consists in 90% UV-A and 10% UV-B, while UV-C 
and almost all UV-B (80–90%) are absorbed by ozone layer [5,6]. The biological effect induced by 
UV depends largely on wavelength [7,8]. The hypothesis is that UV wavelength-specific “action 
spectrum” is stemmed from distinct direct damages to various biomolecules. Conjugated bonds, linear 
repeats or ring structures in organic molecules absorb shortwave UV radiation (200–300 nm). Proteins 
containing tryptophan or tyrosine can therefore absorb UV radiation and start up photochemical 
reactions causing alterations in signaling pathways. UV-A and UV-B portion has a strong carcinogenic 
effect on the skin [9–11] to directly or indirectly induce DNA damage leading to genomic mutations 
and modified gene expression [8,12,13]. UV-C has also been described as inductor of genetic and 
cellular modifications in experimentally assays [14]. 
Exposure to UV-A leads to oxidative DNA modifications including the formation of 8-hydroxyguanine, 
DNA-protein cross-linking, abasic sites, and DNA strand breaks [7,15]. In contrast, the shorter 
wavelengths, UV-B and UV-C, directly damage DNA, causing the formation of cyclobutane pyrimidine 
dimers or 6–4 photoproducts [11,14]. In addition to DNA damage, UV enhances the production of 
reactive oxygen species (ROS) and induces activation of specific signal transduction pathways, 
resulting in altered gene expression that induce senescence, cell cycle arrest and cell death [16–18]. 
2. Signal Transduction Pathways in the Cellular Response to UV Radiation 
UV radiation is one of the most important kinds of environmental stresses for skin damage. 
Exposure to UV is known to induce clustering of some kinds of cell-surface receptors and to 
transducer some cell survival and proliferation signals [19,20]. Skin cells respond to damage by 
triggering the activation of cell surface receptors, such as epidermal growth factor receptor (EGFR) 
and tumor necrosis factor receptor (TNFR) [19,21], and activate intracellular signaling mediated by 
SRC family of tyrosine kinases [22], the small guanosine triphosphate binding proteins, RAS and  
RAC [23], phosphatidylinositol 3-kinase (PI-3K) [24], mitogen-activated protein kinases (MAPKs) 
pathways [25], ataxia telangectasia mutated (ATM) [26] and ribosomal S6 kinases (RSK) [27]. 
Activation of intracellular signaling pathways in response to UV irradiation induces various 
transcription factors that transactivate genes involved in DNA repair, DNA synthesis, transcription and 
cell cycle regulation [17] (Figure 1). The effects to UV radiation on gene expression could be 
classified as early or late events, according to the activation of specific genes and proteins; these UV 
responses are important in determining cell fate, such as growth arrest, apoptosis and survival. UV 
radiation activates different signal pathways in a time, dose and wavelength-specific manner [17,28].  Int. J. Mol. Sci. 2012, 13 145 
 
 
Figure 1. Regulation of proliferation and survival pathways by protein kinases activation 
in response to UV radiation. Mitogen-Activated Protein Kinases (MAPK) family and 
Phosphoinositide 3-Kinases (PI-3K) signaling activation as an outcome of Epidermal 
Growth Factor Receptor (EGFR) activation and/or increase in intracellular Reactive 
Oxygen Species (ROS) levels resulting from UV radiation. MAPK and PI-3K pathways 
can regulate each other in response to UV radiation; however extracellular signal-regulated 
kinase (ERK), p38K and c-Jun NH2-Terminal Kinases (JNK) activate specific transcription 
factors, which regulate the expression of genes participating in proliferation or cell survival. 
PI-3K activates AKT, which leads to induction or repression of cell survival and apoptosis. 
UV radiation is also able to activate protein kinases to regulate protein translation through 
ERK pathway activation.  
 
2.1. UV-Radiation Activates MAPK Signaling Pathways  
MAPKs belong to the serine/threonine protein kinases family that is activated by several stimuli, 
including UV irradiation [25]. The MAPK signaling pathways are, in general, subdivided into three 
different pathways, namely the extracellular signal-regulated kinases (ERK), p38 MAPK (p38 kinase), 
and c-Jun NH2-terminal kinases (JNK) signaling pathways [29], which are activated by dual 
phosphorylation of threonine and tyrosine, at TX-Y motifs within their activation loops. Each member 
of this family can be activated in response to different stimuli and they also have specific intracellular Int. J. Mol. Sci. 2012, 13 146 
 
 
targets. The ERK cascade is generally activated by mitogenic stimuli, and evidence suggested that it 
mediates both cell proliferation and survival, whereas the JNK and p38 kinase pathways are activated 
in response to cellular stress, and appear to exert both protective and pro-apoptotic effects [30–32]. UV 
radiation could activate the three subgroups of the MAPK family. In fact, some reports suggest that 
MAPK pathway is the central event that links UV-induced intracellular signal to the nuclear response 
and modify DNA damage-originated cellular response [25]. Previous reports suggested that induction 
of distinct MAPK signaling pathways by UV is wavelength-specific. Apparently, UV-A induces 
stronger activation of ERK but JNK is principally activated by UV-C, while p38 kinases could be 
activated in response to any UV wavelength to modify DNA damage response [25,33]. Because the 
UV-C component of sunlight is filtered by the atmosphere and does not reach the earth’s surface, here 
we will mainly focus in the studies about activation of MAPK pathway in response to UV-A and  
UV-B radiation as they are more relevant for skin carcinogenesis. 
Activation of MAPK by UV may result from the EGFR-tyrosine kinase (TK) domain activation, 
although the precise mechanism of UV irradiation induced-EGFR activation has not been elucidated 
yet. It has been suggested that UV irradiation might lead clustering of receptors in cell membrane surface 
in order to allow autophosphorylation and activation of intracellular signaling pathways [20,34]. Other 
works indicated that EGFR activation by UV irradiation might depend on the ROS generation, 
particularly the increased intracellular hydrogen peroxide (H2O2), which has been associated with 
phosphorylation of the EGFR-TK domain [20]. The activation of three MAP kinases was prevented by 
antioxidant reagents, suggesting that an oxidative signal initiates these responses [35]. Recently, Xu 
and co-workers reported that UV irradiation induce EGFR nuclear translocation depending of 
phosphorylation of tyrosines in TK domain in human keratinocytes [36]. The biological function of 
nuclear EGFR remains unclear. It has been suggested that EGFR nuclear may phosphorylate nuclear 
proteins and transactivate genes [37,38]. These observations suggested that nuclear EGFR in UV 
radiated cells might regulate cell proliferation. ERK pathway is primarily activated in response to 
activation of growth factors, suggesting that activation of this pathway might result from EGFR 
activation in response to UV-A, whereas activation of JNK and p38 kinases is directly induced by 
stress, including UV-B and UV-C radiation [39]. However, when p38 kinase activation by UV-B 
exposure is mediated by EGFR, it is associated with protection against apoptosis [40], while ERK and 
JNK activation in response to UV-B radiation could be regulated by protein kinase C (PKC) and is 
associated to cell proliferation [41]. Phosphorylation of JNK and p38 kinase by UV-B irradiation 
might result in down regulation of ERK signaling [41].  
In human keratinocytes, UV-A and UV-B stimulate the activation MAPK pathways [42], particularly, 
ERK1, ERK2 and JNK kinases, but p38 is fewer stimulated by UV-A. Interestingly, MAPK and 
transcription factors as AP-1 are not activated in mouse keratinocytes in response to UV-A and UV-B, 
which suggested that a human component, distinct from kinases, could regulate the MAPK activation 
in human keratinocytes. UV-A radiation stimulates ERK signaling pathway in response to activation of 
EGFR, SRC, RAS and RAF proteins in NCTC 2544 keratinocytes [43]. UV-B mainly acts through 
JNK and has a weak effect on ERK in human epidermal keratinocytes [44]. In normal human 
epidermal melanocytes, UV-A increases ERK phosphorylation but it has no effect on the activation of 
JNK and p38 kinases [45]. MAPK pathways activation is a mechanism for causing early-response gene 
expression by controlling the activities of several transcription factors. Activated MAPKs translocate Int. J. Mol. Sci. 2012, 13 147 
 
 
to the nucleus, where they phosphorylate target transcription factors, including AP-1, NF-B, and p53. 
Phosphorylation of transcription factors and regulatory cell survival proteins is mediated by activation 
of effector kinases downstream of the MAPK signaling cascade. UV-B stimulates the activation of 
JNK1, p90 ribosomal S6 kinase 2 (RSK2) and mitogen-and stress-activated protein kinase (MSK1), 
which are downstream of ERK and p38 kinase, respectively [29].  
2.2. UV Radiation-Induced Phosphatases  
MAPKs are inactivated by dephosphorylation induced by mitogen-activated protein kinase 
phosphatases (MKPs), thus regulating the physiological outcome of signaling in response to UV 
radiation. MAPKs are the central element of the signaling cascade that links UV-induced intracellular 
signals to the nuclear responses by phosphorylated transcription factors [25]. MAPK are known to be 
differentially activated depending on dose and wavelength of UV radiation [25,33] and phosphatases 
activation in response to UV stimulus may be an important mechanism of regulation of cell response  
to UV irradiation. Phosphatase 2A (PP2A) is a major protein serine/threonine phosphatase that 
participates in many signaling pathways in mammalian cells [46]. UV-induced PP2A activation 
resulted in down-regulation of p38 MAPK and Akt activities, and diminished apoptosis in human 
keratinocytes. These findings suggest that PP2A may maintain the equilibrium between cell survival 
and cell death in UV irradiation-keratinocytes response in p38 MAPK/Akt-dependent manner [47].  
The c-JUN-JNK and p53-p38 kinase pathways may regulate activation of wild-type p53-induced 
phosphatase (Wip1) in response to UV-radiation. Wip1 dephosphorylates several proteins, included 
MAPK activated by stress stimuli. Apparently, p38 kinase-activated p53 is more efficient to activate 
Wip1, than c-Jun-JNK. As the pathways execute somewhat different cellular responses with regard to 
cell cycle arrest and apoptosis in response to UV irradiation, Wip1 may regulate negatively UV 
irradiation-induced apoptosis by dephosphorylate some kinases [48]. EGFR activation in UV   
radiated-cells may be result of intercross of EGFR in cell membrane or due to phosphorylation induced 
by ROS. Protein-tyrosine phosphatase (PTP) family can dephosphorylate EGFR in order to negatively 
regulate its activity. PTP contain an active site cysteine residue, which is required for phosphohydrolase 
activity. This active site cysteine is highly susceptible to oxidation by ROS, particularly by H2O2 [49]. 
This mechanism could be important for activation of EGFR by UV irradiation. Therefore, inactivation 
of PTP activity as a consequence of intracellular ROS production may regulate activation of EGFR by 
UV radiation [50,51]. Activation of kinases and phosphatases in UV irradiated cells may represent a 
feedback mechanism to regulate the ultimate fate of the cell. 
2.3. UV Radiation Induces PI-3K Pathway for Promoting Cell Survival 
One of the best characterized effectors of cell survival and proliferation is the phosphoinositide  
3-kinases (PI-3K) pathway [52]. When active, PI-3K converts phosphatidylinositol-(4,5)-bisphosphate 
(PIP2) into phosphatidylinositol-(3,4,5)-trisphosphate (PIP3). PIP3, in turn, binds the pleckstrin 
homology (PH) domain of Akt, stimulating its kinase activity. Akt, also known as protein kinase B,  
is catalytically activated by phosphorylation at Thr308 and Ser473 [53]. Recently, many new 
downstream targets of Akt have been identified and shown to promote proliferation by facilitating cell 
cycle progression, or raise survival by transcription-dependent or transcription-independent means [54] Int. J. Mol. Sci. 2012, 13 148 
 
 
or by phosphorylation of other proteins that affect apoptosis and cell proliferation [53]. UV-B exposure 
may stimulate PI-3K activity more strongly that exposure to UV-A [55]. UV-B irradiation induces 
survival signals via activation of PI-3K-Akt pathway [56]; this activation could be a direct effect of 
UV or via activation of EGFR [51]. This activity was associated with overexpression of c-FOS and 
phosphorylation of Akt and p70
s6k. UV induces suppression of cell death through phosphorylation of 
apoptotic proteins and Akt activates transcription factors in order to stimulate genes that promote 
survival [53]. In other words, the activation of receptor cell membrane surface, i.e., clustering of 
receptors (dimerization) in response to UV-B radiation, results in PI-3K activation.  
The activation of PI-3K-Akt pathway is directly activated by EGFR activation in response to UV-B 
irradiation, but activation of this pathway is weaker in response to UV-A radiation. Activation of  
PI-3K-Akt pathway can induce phosphorylation and activation of other kinases, such as p70
s6k and 
p90
RSK, to promote synthesis and activation of transcription factors for the expression of genes 
associated with cell survival [55]. 
2.4. RSK Activation and UV Radiation 
UV-A-induced signal transduction leads to the activation of a complex network of downstream 
effector molecules, including RSK p70
s6k and p90
RSK, also known as MAPKAP-K1, which in turn 
phosphorylate the 40S ribosomal protein S6, resulting in an increase of the translational machinery 
component [57]. p90
RSK is a member of the family of 90-kDa ribosomal S6 kinases, which are 
phosphorylated by ERKs. p90
RSK is involved in signal transduction leading to proliferation, 
differentiation, and apoptosis [58]. In response to UV-A irradiation, EGFR activates p70
s6k and p90
RSK 
kinases through the activation of ERK, but not JNK and p38 [33,59]. The activation of RSKs can occur 
by the MAPK pathways or PI-3K according to the phosphorylation site of each kinase, i.e., MAPK and 
Akt phosphorylate different RSK protein residues [58]. p70
s6k activation in response to UV-A 
irradiation is mediated by the activation of EGFR and PI-3K-Akt. The effects on phosphorylation and 
activation of Akt and p70
s6k may be mediated by MSK1 in response to activation of p38 and ERK, but 
not JNK [59]. EGFR activation in response to UV-A irradiation activates p70
s6k and p90
RSK kinases 
through the activation of ERK. An increased activation of basal and EGF-inducible MAPK, p90
RSK 
and p70
s6k is associated with the activation of AP-1 in cell transformation and tumor promotion [60]. 
3. ATM and UV Radiation  
ATM is a member of the PI-3K family [61]; it is a serine-threonine protein kinase with a   
carboxy-terminal domain similar to the catalytic subunit of PI-3K. In particular, ATM binds to and 
phosphorylates the tumor suppressor p53 in response to DNA double-strand breaks (DSB) [62]. Both 
p53 and ATM function as tumor suppressors [63]. Experimental knockout of both p53 and atm genes 
resulted in a marked acceleration of tumorigenesis in comparison with that observed with a knockout 
of only one of these genes [64]. ATM does not only regulate the response to DSB (see section 4) but it 
also plays an important role in the response to oxidative stress and for modulating cell growth through 
growth factor receptors [26,65]. ATM is activated by UV-A and is involved in the cellular decision to 
trigger p53- and JNK-dependent apoptosis after radiation exposure [26]. ATM is also activated in 
response to ionizing radiation [66]. Unlike UV-A, UV-C does not activate ATM [26]. Instead, UV-C Int. J. Mol. Sci. 2012, 13 149 
 
 
appears to stimulate ATM-related (ATR), a kinase structurally and functionally related to ATM, that 
may function as a sensor of DNA damage to activate JNK and p53 signaling leading to apoptosis [67]. 
Thus, these two related kinases, ATM and ATR, may be selective sensors of different types of cellular 
stress, with ATM responsive to UV-A and ionizing radiation and ATR responsive to UV-C irradiation. 
Activation of survival pathways and cell proliferation induced by diverse UV wavelengths occurs 
through a complex network of protein kinases (Table 1). The activation of MAPK pathway by   
UV-radiation, not only has association with activation of membrane receptors, such as EGFR, but it is 
also associated with increased intracellular ROS levels. UV radiation can promote cell survival 
through PI-3K-Akt pathway, in a dependent or independent way of EGFR activation, according to UV 
wavelength, time exposure and dose. MAPK pathway could regulate the PI-3K activity in response to 
UV-irradiation independently of EGFR activation. Some investigators have reported that the activation 
of AP-1 and NF-κB transcription factors by UV radiation is mediated through membrane-associated 
signaling proteins and is not dependent on a nuclear signal [68]. DNA damage is directly induced by 
UV exposure, and is an important mechanism for UV-induced tumor initiation [69]. Cell response to 
DNA damage includes cell cycle G1-arrest through ATM and ATR activation, using or not the p53 
signal transduction pathways. Therefore the signaling from nucleus in response to UV-irradiation 
could be regulated by p53, which is found to be a negative regulator of AP-1 and NF-κB activation in 
response to UV radiation. This mechanism is linked, on one hand, with the inhibition of JNK and p38 
pathway but not ERK, and on the other hand, with the overexpression of PTEN, which negatively 
regulates activation of PI-3K-Akt pathway. Both events are related to the low activation of AP-1 and 
NF-κB [8].  
Table 1. Protein kinases and transcription factors activated by specific UV wavelengths. 
  MAPK pathway  PI-3K pathway  Transcription factors 
UV-A  EGFR, SRC, RAS, RAF,  
ERK1/2, p70
s6k and p90
RSK 
ATM  c-JUN, Nrf2, NFAT  
UV-B  PKC, JNK, p38 kinase,  
RSK2, MSK1  
EGFR, PI-3K, Akt, 
p70
s6k and p90
RSK  
c-FOS, NF-κB NFAT  
UV-C  EGFR, SRC, ERK, p38 kinase 
JNK1/2  
ATR   AP-1  
4. Role of Transcription Factors in Response to UV Radiation 
Exposure to UV leads to premature aging of the skin and it also increases the risk of acquiring 
cancer. UV-B radiation of cells induces the activation of specific transcription factors, which in turn 
regulate the expression of a number of genes termed the “UV response genes”. Two transcription 
factors that are activated in this way are the activator protein-1 (AP-1) and NF-κB [9]. The study of 
these two transcription factors and the cross-talk between them in response to UV-B exposure may 
help to the development of new chemopreventive strategies for the prevention of UV-B induced   
skin carcinogenesis. 
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4.1. The Nuclear Factor NF-κB 
NF-κB represents a family of transcription factors involved in the regulation of inflammation, 
immune response, development, cellular survival, and cell proliferation. They are the effectors of a 
signaling system that is responsive to a large number of stimuli, including inflammatory cytokines 
recognized by TNFR, and pathogens and virus recognized by Toll-like receptors (TLRs), and receptors 
of the NACHT-LRR (leucine-rich repeat) families [70]. NF-κB also regulates the expression of genes 
outside of the immune system. In the skin, NF-κB plays a role in epidermal homeostasis. The range of 
stimuli activating NF-κB is extensive and continuously growing, which emphasizes its key role in 
transcriptional responses. Notably, NF-κB has important functions in the transcriptional response to 
cytotoxic agents like chemotherapeutic drugs, oxidative and physical stress, UV and ionizing radiations. 
In addition, recent work has highlighted its role in development and physiology of tissues including 
mammary gland, bone, and skin. Thus, the NF-κB system operates on transient or short timescales, 
relevant to inflammation and immune responses, and on longer-term timescales during cell differentiation 
and organ formation [71].  
NF-κB exists in the cytoplasm as homodimers or heterodimers of a family of structurally related 
DNA-binding proteins [72]. In mammals, NF-κB family members are represented by five “Rel” 
proteins: RelA (p65), c-Bel, RelB, and two “NF-κB” proteins NF-κB1 (p50/p105) and NF-κB2 
(p52/p100), which dimerize in almost any combination to activate transcription. NF-κB 1 and NF-κB2 
are synthesized as large precursors (p105 and p100) and processed to generate the mature transcriptional 
active proteins. Only RelA, c-Rel, and RelB, but not p50 or p52, share the C-terminal transactivation 
domains, whereas Rel and NF-κB B proteins contain the N-terminal Rel homology domain (RHD), 
which is involved in dimerization, DNA binding and nuclear localization. In most cells, NF-κB is 
present as a latent and inactive cytoplasmic complex bound to inhibitory IκB proteins. In the canonical 
NF-κB activation pathway, the activity of NF-κB is negatively regulated by interaction with inhibitory 
IκB factors (IκBα, IκBβ, IκBγ, IκBδ, IκBε, and Bcl-3), which prevents DNA binding and promotes 
cytoplasmic accumulation of the interacting p50/RelA dimeric complex. IκB proteins have different 
affinities for diverse NF-κB dimers, which greatly contributes to the complex fine-tuning of NF-κB 
functions [73]. Positive regulation of NF-κB is controlled by the IκB kinase (IKK) complex, which is 
in turn activated by cytokines, growth factors, antigen receptors, MAPKs and other kinases. IKK 
complex, which contains the IKKα and IKKβ catalytic subunits and the regulatory scaffold sensing 
protein called NF-κB essential modulator (NEMO), phosphorylates IκB proteins leading to their 
ubiquitination and subsequent proteasome-dependent degradation [72]. The resulting nuclear accumulation 
of the released NF-κB complexes leads to transcriptional activation of targets genes. Inputs for the 
classical pathway include TNFR1/2, TCR and BCR, TLR/IL-1R, among others. In the alternative 
pathway, activation of IKKα occurs by the activity of NF-κB inducing kinase (NIK) that leads to the 
phosphorylation and processing of p100 bound to RelB, generating p52/RelB heterodimers, which in 
turn translocate to nucleus to activate gene transcription. Activating signals for the alternative pathway 
include ligation of LTβR, BAFFR, and CD40R [74]. An important issue about the cellular response to 
UV irradiation is the existence of crosstalk between NF-κB and specific signaling pathways, including 
the MAPKs, such as JNKs, ERKs and p38 MAP kinases. These observations have been extensively 
reviewed [75], therefore they will not be discussed here.  Int. J. Mol. Sci. 2012, 13 151 
 
 
UV-B radiation of mammalian cells induces the activation of several transcription factors including 
NF-κB and the subsequent transcription of genes [9]. Here, we reviewed relevant aspects about NF-κB 
activation in the context of UV-induced stress. The original evidence for NF-κB regulation by UV 
comes from the initial observation that UV exposure of culture cells induces transcription from the 
long terminal repeat (LTR) promoter of human immunodeficiency virus 1 (HIV-1), the collagenase 
gene and the cellular oncogene fos. Transcriptional activation of HIV-1 depends on the two   
NF-κB-binding sites located in the LTR (-105 and -79 nucleotide positions), whereas the heterodimer 
of JUN and FOS (AP-1) appears to bind to the collagenase enhancer, and the serum response factors 
p67 and p62 bind to c-fos gene promoter. In addition, DNA-binding activities of the factors 
recognizing the HIV-1 and collagenase enhancers were augmented in extracts from UV-treated cells. 
These data indicated that UV, like TNFα or IL-1α, targets NF-κB to the nucleus. However, the 
canonical NF-κB activation mechanism described above does not occur in UV-induced early phase (12 h).  
NF-κB-dependent HIV-LTR activation required lower doses of UV-C (2 J/m
2) in cells from patients 
with Xeroderma pigmentosum group A (XPA) than in cells from healthy human individuals (20 J/m
2), 
which supports the idea that DNA damage is required for proper NF-κB activation [76].  
Other studies showed that UV-C radiation results in degradation of NF-κB inhibitor IκBα, nuclear 
translocation of RelA (p65), and induction of NF-κB DNA-binding activity. It was suggested that UV-C 
induces phosphorylation-independent degradation of IκBs by the ubiquitin and proteasome pathway. 
Interestingly, expression of a catalytically inactive IKKβ mutant did not prevent NF-κB activation by 
UV-C, indicating that activation occurs through a mechanism independent of IKK activation [77].  
UV-induced NF-κB activation depends on phosphorylation of IκBα by casein kinase II (CK2) through 
a mechanism that depends on the activation of p38 MAP kinase (Figure 2). Notably, inhibition of this 
pathway prevents UV-induced IκBα degradation and increases UV-induced cell death [78]. 
NF-κB activation may occur sequentially in time by different mechanisms. For instance, it has been 
observed that UV radiation induces a delayed and prolonged (3–20 h) activation of NF-κB, whereas 
TNFα exposure induced an immediate and acute (10–90 min) activation. It was reported that UV 
causes IκB degradation in an early phase (30 min to 6 h), which does not involve the phosphorylation 
of IκB by IκB kinase (IKK complex); while a late mechanism established in cultured cells beyond 15 h 
requires the phosphorylation of IκBα, and the DNA damage-induced release of IL-1α which in turn 
binds to its receptor and activates the IKK complex. This late phase of NF-κB activation appears to be 
due to DNA damage-dependent activation of the IKK complex. In contrast, early phase activation was 
independent of DNA damage [79]. UV-B radiation induction of NF-κB activity independently from 
chromosomal DNA damage has been previously observed using UV irradiated cell-free cytosolic 
extracts [80]. In agreement with these observations, the UV response does not require a signal 
generated in the nucleus and is not dependent on DNA damage. Enucleated cells are fully responsive 
to UV irradiation through NF-κB induction and activation of additional key signaling events [68]. Int. J. Mol. Sci. 2012, 13 152 
 
 
Figure 2. Signaling pathways leading to transcription factors activation in response to   
UV-radiation. UV-induced Nuclear Factor kappa B (NF-κB) pathway activation depends on 
phosphorylation of IκBα by Casein Kinase II (CK2) through the activation of p38-MAP kinase. 
Phosphorylation-induced degradation of IκBα releases NF-B subunits RelA/p50, which enter 
into nucleus to activate gene transcription of targets genes. UV-induced phosphorylation of 
Eukaryotic Translation Initiation Factor 2α (eIF2α) inhibits de novo IκBα translation, whereas 
the existing IκBα is degraded, leading to NF-κB activation. The chemopreventive inhibition of 
NF-κB by natural compounds parthenolide and magnolol, as well as p38 blocking by   
(−)-Epigallocatechin 3-gallate (EGCG) is depicted. In AP-1 pathway, UV-induced activation 
of membrane receptors leads to the activation of MEKK, c-Jun NH2-Terminal Kinases (JNK), 
and p38. MAPKs phosphorylate transcription factors leading to increased expression of AP-1. 
In Nrf2 pathway, Nrf2 acts as a sensor for oxidative and electrophilic stress. In these conditions, 
phase 2 inducers cause the modification of Keap1 and/or phosphorylation of Nrf2 resulting in 
the release of Nrf2 from Keap1. Nrf2 is stabilized and translocate to the nucleus, where it 
heterodimerizes with MAF proteins, to bind to the antioxidant responsive element which leads 
to activation of cytoprotective genes.  
 
A novel mechanism mediating the early phase-NF-κB activation by UV radiation involved an 
endoplasmic reticulum-stress-induced translational inhibition pathway [81]. UV-induced phosphorylation 
of the eukaryotic translation initiation factor 2α (eIF2α), inhibits de novo IκB translation, whereas the 
existing IκB is degraded through the ubiquitin-dependent proteasomal pathway, leading to NF-κB Int. J. Mol. Sci. 2012, 13 153 
 
 
activation in mouse embryo fibroblasts. In this model, inhibition of IκB mRNA translation was 
initiated by UV-C-induced (0.03 kJ/m
2) phosphorylation of eIF2α through activation of the protein 
kinase like endoplasmic reticulum kinase (PERK) leading to early phase activation of NF-κB. Other 
studies evidenced the activation of NF-κB via a non-canonical pathway. It was reported that both 
TNFα and UV-B stimuli enhanced NF-κB DNA-binding activity in normal human keratinocytes, 
however these events occur through different mechanisms. NF-κB response following TNFα treatment 
occurs by the canonical pathway and leads to IκBα phosphorylation and degradation; whereas 
activation of NF-κB by UV-B is independent of IκBα degradation. Moreover, TNFα or UV-B 
treatment results in the activation or repression of a subset of specific genes [82]. These observations 
provide further experimental evidence about the stimuli and cell-type dependence of NF-κB activation.  
4.2. Chemopreventive Intervention of NF-κB Pathway 
The UV induced-skin photoaging is characterized by keratinocytes proliferation and degradation of 
collagen fibers, leading to skin wrinkling and laxity. It is well known that NF-κB activity greatly 
contributes to the skin photoaging process. Therefore, it is plausible that inhibition of NF-κB pathway 
could directly prevent skin photoaging effects. The natural compound parthenolide, a sesquiterpene 
lactone from the plant feverfew (Tanacetum parthenium) can inhibit the gene expression mediated by 
NF-κB and the production of basic fibroblast growth factor (bFGF) and matrix metalloproteinase-1 
(MMP-1). Notably, this compound also inhibited the UV-B-induced proliferation of keratinocytes and 
melanocytes in mouse skin [83,84]. Parthenolide induced apoptosis and inhibited cell proliferation and 
the expression of VEGF in vitro. Moreover, inhibition of NF-κB activity by expressing a mutant IκBα 
suppressed lung cancer metastasis in vivo [85]. Magnolol is a bioactive compound found in the 
Japanese whitebark Magnolia (Magnolia ovovata)  that  specifically inhibited the NF-κB-dependent 
transcription. In addition, external swabbing with Magnolia extracts prevented skin photoaging process 
in mice. Magnolol was also effective in inhibiting the production of bFGF and MMP-1 from cells 
overexpressing p65, a major subunit of NF-κB. Interestingly, magnolol did not affect the phosphorylation 
and degradation of IκBα, but it inhibited the nuclear translocation of the activated NF-κB [86]. 
Treatment of normal human epidermal keratinocytes with grape seed pro-anthocyanidins (GSP) inhibited 
UV-B-induced hydrogen peroxide, lipid peroxidation, protein oxidation, and DNA damage. GSP also 
inhibited UV-B-induced phosphorylation of ERK1/2, JNK, and p38. Moreover, GSP inhibited the  
UV-B induced activation of NF-κB/p65 through inhibition of degradation and activation of IκBα and 
IKKα, respectively [87]. (−)-Epigallocatechin 3-gallate (EGCG) from green tea leaves   
(Camellia sinensis) is a potent antioxidant that may have therapeutic applications in the treatment of 
many disorders (e.g., inflammation, cancer). It has been described that EGCG is able to inhibit p38, 
therefore blocking NF-κB activation and c-fos transcription (Figure 2). In conclusion, these findings 
suggest that NF-κB inhibitors and modulators are useful in preventing the skin photoaging,   
UV-radiation-induced oxidative stress, as well as proliferation and metastasis of tumoral cells. 
Alternative strategies to target NF-κB functions have been developed for potential therapeutically 
intervention. Experimentally induced sunburn reactions in mice could be specifically prevented by 
blocking UV-induced, NF-κB-dependent gene transactivation with oligodeoxynucleotides (ODNs) 
containing the NF-κB cis element (NF-κB decoy ODNs). Local UV-induced inflammatory changes Int. J. Mol. Sci. 2012, 13 154 
 
 
represented by cellular swelling, leukocyte infiltration, epidermal hyperplasia, and accumulation of 
proinflammatory cytokines IL-1, IL-6, TNFα, and VEGF were inhibited by topically applied decoy 
ODNs [88]. Similarly, NF-κB decoy ODNs lead to increased UV-B induced apoptosis of mouse 
transfected keratinocyte Pam 212 cells. In addition, cell sunburn formation was significantly enhanced 
by topical NF-κB decoy ODNs treatments, while UV-induced erythema was not affected [89]. These 
data promise for the potential application of decoy ODNs targeting NF-κB function as a new 
therapeutic modality for the treatment of skin diseases. 
4.3. The Activator Protein-1: AP-1 
Exposure to UV-B leads to the activation of cell surface growth factor and cytokine receptors, 
which induces multiple signal transduction pathways that converge to stimulate DNA binding of 
specific transcription factors, such as the activator protein-1 (AP-1), and subsequent modulation of 
gene expression [9]. The AP-1 transcription factor family is composed of homodimers or heterodimers 
of basic region-leucine zipper (bZIP) proteins that belong to the JUN (c-JUN, JUNB and JUND), FOS 
(c-FOS, FOSB, FRA-1 and FRA-2), Jun dimerization partners (JDP1 and JDP2), the activating 
transcription factors (ATF2, LRF1/ATF3 and B-ATF) and musculoaponeurotic fibrosarcoma (MAF) 
subfamilies [90]. The bZIP domains allow binding to other proteins that contain a similar bZIP domain. 
DNA-binding specificity and affinity is governed by the broad combinatorial possibilities resulting from 
the large number of AP-1 proteins, which greatly increases the spectrum of regulated genes.  
AP-1 transcription factor is mainly composed of JUN, FOS and ATF dimers, which after activation 
by phosphorylation, mediate gene expression regulation in response to a variety of physiological and 
pathological stimuli, including cytokines, growth factors, hormones, stress signals, bacterial and viral 
infections, as well as oncogenic stimuli. In turn, AP-1 regulates a wide range of cellular processes, 
including cell proliferation, differentiation, survival, apoptosis and transformation [91]. These effects 
are mediated through activation and binding of AP-1 dimers to DNA consensus sequences, leading to 
expression regulation of target genes, such as collagenase-1, c-JUN, cyclin D1, p21, p19 and p16 [92]. 
JUN-FOS heterodimers bind to the heptamer consensus sequence known as the TPA responsive 
element (5′-TGA(C/G)TCA-3′), whereas Jun-ATF dimers bind with higher affinity to the consensus 
sequence known as the cyclic AMP responsive element (5′-TGACGTCA-3′). 
Transactivation of AP-1 is required for tumor promoter-induced transformation in mouse epidermal 
JB6 cells and for progression in mouse and human keratinocytes. The relevant roles of AP-1 in skin 
cancer promotion were early described in clonal genetic variants of mouse epidermal JB6 cells that are 
susceptible or resistant to promotion of transformation by phorbol ester 12-O-tetradecanoylphorbol-13-
acetate (TPA). Using constructs containing AP-1 cis-enhancer sequences upstream of a reporter gene, 
Bernstein and Colburn [93] evidenced an association between induced AP-1 function and oncogenic 
transformation in JB6 cells. Constitutive AP-1 DNA binding and subsequent transactivating abilities 
occur in malignant but not in benign mouse epidermal cell line 308, suggesting that AP-1 activation 
resulted in deregulation of gene expression leading to cell neoplastic transformation. In contrast, stable 
expression of a c-JUN deletion mutant (TAM67) in two malignant mouse epidermal cell lines blocked 
tumor formation in nude mice [94]. Exposure of dominant negative TAM67 under the control of the 
human keratin-14 promoter blocked tumor promoter-induced AP-1 transactivation and neoplastic Int. J. Mol. Sci. 2012, 13 155 
 
 
transformation [95]. Expression of TAM67 inhibited AP-1 and NF-κB transactivation and suppresses 
anchorage independent growth of HPV immortalized human keratinocytes, revealing the existence of a 
“crosstalk” between AP-1 and NF-κB transcription factors [96]. The same group reported additional 
evidences suggesting that “cross-coupling” of AP-1 and NF-κB activation might contribute to the 
process of tumor promoter-induced transformation induced by TPA and TNFα [97]. Using okadaic 
acid, a prototypical non-phorbol ester skin tumor-promoting agent, in transgenic mice expressing 
TAM67, Thompson and coworkers [98] observed that TAM67 was able to block okadaic acid-induced 
skin tumor promotion, which indicates that functional AP-1 is required for TPA induced tumor 
promotion in multistage mouse skin carcinogenesis in vivo. Potential target genes responsible for 
TAM67 inhibition of 7,12-dimethylbenz(a)anthracene-TPA-induced tumorigenesis were identified 
using microarray expression profiling of epidermal tissues. Cyclooxygenase-2 (Cox-2/Ptgs2) and 
osteopontin (Opn/Spp1), which are known to be important contributors in driving carcinogenesis, were 
identified as TAM67-modulated genes [99]. Cooper et al. [100] expressed the TAM67 mutant 
transgene in the epidermis of SKH-1 hairless mice and bred with mice expressing an AP-1 luciferase 
reporter gene. Authors showed that expression of TAM67 efficiently inhibits UV-B-induced squamous 
cell carcinoma number and size in the SKH-1 hairless mouse, which correlated with a diminution in 
cyclin D1 expression. Taken altogether, these data suggested that specific signaling pathways that are 
inhibited by a dominant negative c-JUN are involved in both chemical and UV-B-induced skin 
carcinogenesis. They also evidenced that AP-1 is a good candidate target for the development of 
chemoprevention strategies to prevent sunlight-induced skin cancers. 
Crosstalk between AP-1 subunits and MAPKs may exist. Involvement of signaling molecules in 
AP-1 activation has been reviewed [101]. In addition, crosstalk between AP-1 and NF-κB has been 
recently reviewed [9], thus they will not be discussed here. The roles of p38 and ERK on UV-B 
induced c-fos transcription factor gene expression were previously studied in the human keratinocytes 
cell line FL30 [102]. Using specific inhibitors, authors showed that suppression of both p38 and ERK 
completely blocked UV-B induced c-fos expression. In addition, inhibition of p38 and ERK in a 
squamous cell carcinoma cell line SCL-1 has been shown to inhibit UV-A and UV-B-induced matrix 
metalloproteinases MMP-1 (stromelysin-2) and MMP-10 (interstitial collagenase) expression both   
in vitro [103] and in vivo [104]. These findings identify the JNKs and p38 as important players in  
UV-B-induced AP-1 activation in UV-B-induced skin carcinogenesis, which argues for the identification 
of novel specific inhibitors as chemopreventive agents. 
4.4. The NF-E2-Related Factor 2: Nrf2 
The accumulation of ROS contributes to a wide variety of degenerative diseases including skin 
cancer. Cytoprotection is provided by the expression of antioxidant proteins and phase 2 detoxifying 
enzymes that are induced upon exposure to low levels of electrophiles or oxidative stress. These 
cellular antioxidants prevent the occurrence and reduce the severity and appearance of UV-induced 
photoaging and skin cancer. The protective mechanisms described involves the NF-E2-related factor 2 
(Nrf2), which binds to a cis-acting sequence called the antioxidant responsive element (ARE) or 
electrophile responsive element within the regulatory upstream region of target cytoprotective genes 
coding for antioxidant proteins. Under basal conditions, Kelch-like ECH associating protein 1 (Keap1) Int. J. Mol. Sci. 2012, 13 156 
 
 
regulates the intracellular localization of Nrf2 by direct binding to its N-terminal Neh2 domain [105]. 
Keap1 interaction with Neh2 allows the sequestration of Nrf2 in the cytosol and the enhancement of 
Nrf2 degradation by proteasomes, conferring the fine tuning to regulation of response [106]. During 
periods of oxidative/electrophilic stress, phase 2 inducers cause the modification of Keap1 (Cys151) 
and/or PKC phosphorylation of Keap1 (Ser40) resulting in the release of Nrf2 from Keap1. Nrf2 is 
stabilized and translocates to the nucleus, where it forms a complex with MAF proteins and binds to 
ARE motifs to promote transcription of “anti-oxidant” genes. Therefore, Nrf2 and its cytoplasmic anchor 
protein Keap1, regulate the cellular antioxidant response through the expression and coordinated 
induction of a battery of defensive genes encoding detoxifying enzymes and antioxidant proteins.  
Nrf2 was first isolated as a protein closely related to p45 NF-E2. Four members of the   
p45 NF-E2-related proteins, p45 NF-E2, Nrf1, Nrf2, and Nrf3, have been isolated in mammals and 
referred to as Cap‘n’collar (CNC)-type basic leucine zipper (bZIP) transcription factors [107]. The 
roles of Nrf2 and phase 2 genes in chemoprevention of carcinogenesis have been well described in 
several tissues and organs; however only few studies have focused in the elucidation of their functions 
in skin [108]. Many harmful effects of UV radiation are associated with the generation of ROS, thus 
cellular antioxidants should act to prevent UV-induced skin damage. Keratinocyte growth factor 
(KGF), a potent mitogen for epithelial cells, promotes survival under stress conditions, including ROS 
generation. Braun and colleges [109] reported a role for KGF-regulated Nrf2 in the control of gene 
expression and inflammation during cutaneous wound repair in vivo. UV-A, but not UV-B, could 
activate Nrf2 in dermal fibroblasts to ensure protection of dermis against photo-oxidative stress. In 
addition, using dermal fibroblasts derived from nrf2 or keap1 gene knockout mice, they demonstrated 
that disruption of nrf2 increased the number of apoptotic cells after UV-A radiation, whereas 
disruption of keap1 decreased the apoptotic cell number by half as compared with wild-type animals. 
These observations evidenced that Nrf2-Keap1 complex has an important function in the protection of 
skin against UV-A irradiation. However, the role of Nrf2 in response to UV-B exposure has not been 
clearly demonstrated and contradictory data have been reported [110]. Only low UV-B doses   
(7.5 J/m
2) could stimulate Nrf2 transcriptional activity in normal human fibroblasts. Intriguingly, high 
UV-B dose (20 J/m
2) led to the nuclear exclusion of Nrf2 and down-regulation of chemoprotective 
gene expression [111]. In contrast, Durchdewald et al. [112] reported that electrophilic chemicals, but 
not UV radiation, could activate Nrf2 in mouse keratinocytes.  
These countered points have been reconciled by observations indicating that p53 may compete with 
Nrf2 and suppress the Nrf2 transcription of phase 2 genes [113]. Authors proposed that if the oxidative 
stress causes DNA damage, a second response based on the activation of p53 takes place, which 
induces cell cycle arrest and/or apoptosis. p53 activation counteracts the Nrf2-induced transcription of 
ARE-containing promoters in antioxidant genes. Thus, it seems that a p53-dependant negative control 
on the Nrf2 transactivation should be activated to block the generation of a strong antioxidant 
intracellular environment that could dam the induction of apoptosis. Additional evidences about the 
role of Nrf2 in the UV response of the skin were obtained using a transgenic mice expressing an Nrf2 
mutant (K5cre-caNrf2), which lacks the N-terminal Neh2 domain responsible for binding to the 
inhibitory Keap1, resulting in a specifically activation of Nrf2 in the epidermis. Results showed that 
Nrf2 activates the production and release of glutathione and cysteine by suprabasal keratinocytes, 
resulting in protection of basal cells from UV-B-induced apoptosis through activation of cytoprotective Int. J. Mol. Sci. 2012, 13 157 
 
 
genes. In addition, Nrf2 protects keratinocytes from UV-B cytotoxicity through enhanced ROS 
detoxification [114]. 
The involvement of Nrf2 in skin cancer prevention was demonstrated by auf dem Keller et al. [115]. 
Intriguingly, authors did not find gross abnormalities in the epidermis of transgenic mice, which 
express a dominant-negative Nrf2 mutant in the epidermis; however, the incidence and multiplicity of 
chemically induced skin papillomas were enhanced. In addition, they evidenced that increased 
tumorigenesis results from a reduced basal expression of cytoprotective Nrf target genes, leading to 
accumulation of oxidative damage driving to genomic instability and neoplastic transformation. In 
contrast, Kawachi et al. [116] reported no significant differences in skin carcinogenesis between   
nrf2-null and wild-type mice exposed to chronic UV-B radiation. Notably, they observed that 
epidermal necrosis, inflammatory cell infiltration, sunburn cell formation, accumulation of oxidative 
DNA products and cell apoptosis after acute UV-B treatment (single dose), were more prominent in 
nrf2-null mice, suggesting that the Nrf2-Keap1 pathway plays an important role in protection of the 
skin against acute UV-B reactions.  
A concerted interplay between Keap1-Nrf2-Maf signaling and other signaling pathways such as 
PKC, MAPKs, PI3K, PERK, p38, ERK2 and JNK1 have been reported and reviewed [117–120 and 
therefore will not be discussed here. 
4.5. Chemopreventive Intervention of Nfr2-Keap1 Pathway 
The chemopreventive effects of natural compounds in photo-dermatological reactions caused by 
oxidative stress have been well documented. Exposure to chemopreventive agents produces ROS or 
electrophiles and causes oxidative/electrophilic stress in cells, which induces phase 2 detoxification 
enzymes and antioxidant enzymes [121]. Treatment of mouse and human keratinocytes with sulforaphane, 
a natural compound found in broccoli, Brussels sprouts or cabbages, increases glutathione and phase 2 
enzymes protecting against oxidative stress generated by UV radiation. Moreover, topical application 
of sulforaphane-containing broccoli sprout extracts protects against UV-B (30 mJ/cm
2)-induced skin 
carcinogenesis in SKH-1 high-risk mice, suggesting that this approach constitutes a promising strategy 
for protecting skin against tumor formation after exposure to UV radiation [122]. In other studies, 
quercetin, a polyphenol found in fruits, vegetables, leaves and grains, protected human keratinocyte 
HaCaT cells from UV-A induced apoptosis and DNA damage by enhanced accumulation of Nrf2, 
which leads to elevating intracellular antioxidative activity and reduced production of ROS [123]. 
4.6. Factor of Activated T Cells (NFAT) is Activated in Response to UV Radiation 
NFAT is a family of nuclear transcription factors that are regulated by calcium/calcineurin   
signals [124]. They were identified for the first time as transcription factors of genes associated to 
immune response and play an important role during T cell activation. NFAT is expressed in T cells and 
some tissues such as the nervous system, bone and epidermis, and recent data suggest that NFAT is 
involved in the skin’s responses to UV radiation. NFAT is predominantly located in an inactive 
hyperphosphorylated state in the cytoplasm, but when NFAT is dephosphorylated by phosphatase 
calcineurin, its import into the nucleus in order to regulate gene transcription [125]. The UV-A-induced 
oxidative stress leads to calcineurin activation, therefore, NFAT could be in an active form in response to Int. J. Mol. Sci. 2012, 13 158 
 
 
low doses of UV-A radiation. While high doses of UV-A radiation induce phosphorylation of c-JUN 
through JNK, JNK bound to c-JUN may phosphorylate NFAT. These results suggest that NFAT in 
activate or inactivated state may be depending to different doses of UV-A [126]. Cyclooxygenase 2 
(COX-2) protein levels become elevated in the epidermis of human skin following UV-B irradiation and 
also in squamous cell carcinomas and actinic keratosis. Heterozygous COX-2 knockout mice showed 
that COX-2 is required for the development of UV-induced skin tumors. The COX-2 promoter contains 
binding sites for NFAT, and in some reports, it has been shown that overexpression of COX-2 is 
dependent of NFAT, which has antiapoptotic effect in response to UV-B [127]. This result suggested that 
NFAT in an activated or inactivated state is depending of doses and UV wavelength radiation. UV 
radiation-induced NFAT may be negatively regulated by MAPK activation, while phosphatase 
activations in response to UV irradiation may regulate positively NFAT [128].  
5. Deciphering Cellular Response to UV Radiation in Skin Using Genomic Tools 
Sunburns are largely owing to UV-B radiation that is considered as the most successful inducer  
of damaging effects on epidermis, such as wrinkling, aging, keratosis, cancers of keratinocyte   
origin [129,130, as well as a potential contributing factor to the pathogenesis of melanoma. Several  
in vitro models have been developed to study the molecular mechanism involved in human skin 
pigmentation and cancer [131,132], inflammation and DNA repair processes [133]. These models 
include mono-cultured cell lines, co-cultured melanocytes and keratinocytes, intact skin or suction 
blisters, as well as reconstructed epidermis.  
DNA microarray technology has become one of the crucial tools for understanding the biological 
mechanisms associated with skin damage. One of the first studies showed that UV-B radiation affects 
the expression of at least 198 genes in normal epidermal keratinocytes cultures from human skin [44]. 
At 0.5–2 h after irradiation, alterations in gene expression of transcription factors, kinases, 
phosphatases, proteases, RNA processing enzymes, signal transducers, and cytoskeleton components, 
were notable, which suggests that keratinocytes have sensed DNA damage and changed their 
physiology to respond to UV stimulation. The early induced transcription factors included JUNB, 
JUND, c-FOS, ETR101, EGR1, HRY, and XBP-1. Their expression was relatively fast and short, 
which suggests that they could be activating the expression of DNA damage sensors and DNA repair 
factors. The overexpression of TAFII30, a TATA-box binding protein associated factor, could be 
related to the enhanced transcription observed for many genes. In contrast, UV irradiation induced a 
strong and persistent suppression of c-Myc, which is known to inhibit the expression of DNA   
damage-induced growth-arrest proteins. The regulation of kinases, phosphatases, small GTP binding 
proteins and their associated factors induced three RING3 proteins, which is consistent with the 
activation of intracellular signaling processes. It is known that the main signal-transducing mechanism 
directly induced by UV irradiation implies the participation of JNK and JNK-phosphorylated 
transcription factors [134–136]. The early suppression of the desmosomal proteins was noteworthy; 
since desmosomes keep cells closely attached one to another [137], their reduction may make easy the 
movement of keratinocytes, assembly of the cornified layer, and arrangement of the stratum corneum, 
which is the dead protective layer of skin. The most induced genes early after UV treatment include 
mitochondrial proteins (cytochrome c-1, cytochrome c oxidase subunit VIIb, and cytochrome b) and Int. J. Mol. Sci. 2012, 13 159 
 
 
genes involved in energy generation (NADH dehydrogenase, mitochondrial ATP synthase,   
nucleoside-diphosphate kinase, an electron transfer flavoprotein, and α-enolase). In contrast, both 
transporters and gluconeogenic and lipogenic enzymes expression were repressed.  
At 4–8 h, cells secreted growth factors, and produced cytokines and chemokines to alert the 
surrounding tissues to the UV damage. Specifically, five members of the IL-8 family were induced: 
IL-8, Gro-α, Gro-β, MDCNF and MIP2. These chemokines act as chemotactic and stimulate basophils, 
neutrophils, and macrophages, apparently promoting inflammatory response into UV-damaged tissue 
and activating melanocytes [138]. It has been demonstrated that keratinocytes do not produce 
interferon γ (IFNγ) but they have the capacity to respond to its presence inducing the expression of 
K17, the keratin in contractile epithelia [139]. In fact, at late time points after UV irradiation, IFNγ 
responsive genes were induced, such as p27, 17-kDa/15-kDa protein, IRF7A, hPA28β and IFNγ 
receptor accessory factor 1. At these times, genes for components of the cornified layer of skin were 
induced too, including differentiation markers, such as calgranulin, elafin, involucrin and S100 
calcium-binding protein A13, and four small proline-rich proteins [140], which suggests that the 
epidermal responses to UV comprises the enrichment of stratum corneum through augmentation of the 
cornified, dead, protective layer of skin. It seems that one of the epidermal responses to UV is 
enrichment of stratum corneum.  
A comparison of these data with other reports obtained from several time-course cDNA microarrays, 
revealed a very similar UV-B-regulated gene expression profile in keratinocytes [141–144]. Additional 
outcomes in epidermal keratinocytes showed the induction of neuroendocrine-immune-related genes 
involved in water and salt balance, prostaglandin synthesis, keratinocyte differentiation, as well as 
genes coding for stress effectors, cytokines and metalloproteinases [145]. Remarkably, HaCaT cells 
were able to respond to UV-B radiation in a similar way than healthy epidermal keratinocytes [146]. 
Among 840 genes tested, 192 changed their expression levels at different time points. The genes were 
clustered into four groups in self-organizing maps and classified into nine functional categories 
according to the affected biological processes. Those that were first up regulated and then returned to 
normal levels included genes related to the inhibition of cell growth and the proteasome processing. 
On the other hand, the expression of numerous genes involved in the cytoskeleton dynamic, signaling, 
metabolism and transcription were first down regulated or unchanged and then up regulated, reflecting 
the restoration of UV-B-damaged cellular activities. Another study using cDNA microarray 
technology elucidated the effect of a cytotoxic dose of UV-B on cancer-related genes in human 
epidermal keratinocytes (neonatal) at 1, 6, and 24 h post-radiation. Once verified that viability of the 
irradiated cells was 75% at 24 h post-irradiation, analysis of the hybridization signals revealed that  
27 genes were regulated within 1 h after UV-B treatment. Moreover, 58 and 28 genes were regulated at 
6 and 24 h post-irradiation, respectively. Various cytokeratins and transcription factors were up 
regulated within 1 h post-irradiation. After 6 h, expression of a variety of genes related to growth 
regulation (p21WAF1, notch 4, and smoothened), apoptosis (caspase 10, hTRIP, and CRAF1), DNA 
repair (ERCC1, XRCC1), cytokines (IL-6, IL-13, TGFβ, and endothelin 2), and cell adhesion (RhoE, 
and RhoGDI) were altered in human keratinocytes [147].  
Interestingly, in a squamous cell carcinoma line, the effect of UV-B radiation contrasted from the 
response of normal human keratinocytes. Normal cells were found to be more resistant than carcinoma 
to UV-B-induced apoptosis, and this resistance was principally associated to the secretion of survival Int. J. Mol. Sci. 2012, 13 160 
 
 
factors. The effect of UV-B on normal cells and carcinoma line induced the up regulation of 251 and 
127 genes, respectively, and the down regulation of 322 and 117 genes, respectively, in these cultures. 
Although the response of keratinocytes to UV-B involved control of crucial checkpoint genes, such as 
p53, MDM2, p21(Cip1), DeltaNp63, as well as antiapoptotic and DNA repair genes, little or no change 
in the expression of these genes was detected in squamous cell carcinoma line [148]. Despite the fact 
that keratinocytes are the most plentiful skin cell type, they do not completely represent human skin  
in vivo because epidermis contains Langerhans cells, which are the resident antigen-presenting 
dendritic cells, Merkel cells, the mechanoreceptive cells related to sensory neurons, and melanocytes 
that provide pigments as defense from sunlight and comprise about 10% of all epidermal cells. 
Facultative pigmentation, as a consequence of physiological reaction to UV radiation and skin 
constitutive color, commits the epidermal pigmentation controlled by melanocytes and melanosome 
metabolism [149]. In addition, low doses of UV-B radiation have been shown to cause a greater 
increase in melanin synthesis in human co-culture models based on melanocyte and keratinocyte   
cells [150,151], than in mono-cultured melanocytes [152]. Even though the epidermis might thicken 
with prolonged UV exposure, the melanocytes undertake crucial physiological modifications, 
including bigger dendrite formation, melanogenesis, and melanosome translocation that are responsible 
for maintaining an adequate protection to minimize UV chronic damage [153]. 
Molecular approaches on UV responses have also advanced rapidly using primary melanocyte 
cultures and cultivated melanoma cells. It has been reported that UV exposure induces a G1 arrest in 
melanocytes which is in part due to p53 [154] and p16INK4a [155]. Notably, a polymorphism in p53 
protein (Arg72Pro) is responsible for risk of melanoma [156]. In melanocytes, many molecules are 
induced by UV treatment [157–161]. The activated network contains transcription factors (Id1, N-oct3, 
p73, p53, Mitf), signaling kinases (JNK, ATR, p38, AKT), effectors for cell cycle control (p16INK4a, 
Gadd45, p21CIP), DNA reparation (Gadd45, Ddb2) and survival (Bax, Bcl-2) [162–164]. 
A relevant widespread study evaluated UV-B-mediated alterations in over 47,000 transcripts by 
microarrays assays, using primary melanocytes cultures as model. A set of p53 targets, including the 
cell cycle regulator CDKN1A (p21CIP), WNT pathway regulator DKK1 (dickkopf homolog 1), 
receptor tyrosine kinase EPHA2, growth factor GDF15, ferrodoxin-reductase (FDXR), p53-inducible 
protein (TP53I3), transcription factor ATF3, DNA repair enzyme DDB2, and β-adrenergic receptor 
ADBR2, were identified. Besides, a subgroup of neurite/axonal developmental genes was modulated, 
suggesting that melanocytic and neuronal arborization may have related mechanisms. Compared to 
melanomas, the basal level of many of these p53-responsive genes was greatly deregulated. Genes like 
CDKN1A, DDB2 and ADRB2, showed a decreased expression in melanomas, increasing the probability 
to perform a concomitant function in carcinogenesis events [165]. 
The role of UV-B radiation in skin cancer has been considerably emphasized. In contrast, the adverse 
effects of UV-A have often been dismissed and comparatively less studied. At present, many published 
articles showed the protagonist action of UV-A on skin carcinogenesis. Unlike UV-B, which is partially 
absorbed by the different epidermal layers and does not penetrate into the skin, UV-A rays affect the 
dermal compartment by radically decreasing the amount of superficial fibroblasts in epidermis [166]. The 
prevalence of UV-A mutations in the basal cell layer supports the essential role that UV-A may perform in 
the malignant alterations of human skin [167]. Besides, UV-A radiation induces epidermal lipid peroxidation, Int. J. Mol. Sci. 2012, 13 161 
 
 
which stimulates Langerhans cells migration from the epidermis, thus contributing to UV-induced 
immunosuppression [168], as well as alteration of the expression of TNFα in keratinocytes [169]. 
Gene expression profiles in melanocytes and other types of skin cells submitted to different types of 
UV have been recently reported and potential previously unidentified factors involved in UV-induced 
responses of human skin have been identified. Whole human genome microarray analyses were used to 
characterize human skin in situ and examine how melanocyte specific proteins and paracrine 
melanogenic factors are regulated by repetitive exposure to different types of UV. The results showed 
that UV-B radiation elicited a dramatic increase in a large number of genes involved in pigmentation, 
as well as in other cellular functions, while UV-A had little or no effect on these processes [170]. 
Another study using microarray technology confirmed that UV-A regulates genes involved in 
extracellular matrix homeostasis, oxidative stress, heat shock responses, cell growth, inflammation and 
epidermal differentiation [171]. In addition, modulations for genes previously unknown to be involved 
in the UV-A response, such as PLAB, EPO, HBEGF, IGF1 and TGF-α, all corresponding to growth 
factors family were described. Furthermore, this work also revealed that broad-spectrum sunscreen 
application prior to UV-A exposure abrogated or significantly reduced these effects, because it was 
able to normalize gene expression in both fibroblasts and keratinocytes [171]. 
One last interesting issue is that most experimentation characterizing the molecular effects of sun 
exposure in skin has generally involved solar simulators. In most cases, the aim was to explore a very 
drastic UV radiation panorama, which is barely found in routinely open-air activities. A non-extreme 
UV spectrum denoted as “daily UV radiation” (D-UVR) with a higher UV-A than UV-B radiation 
ratio, has consequently been considered in several experimental projects. The biological impact of 
exposure to low physiological doses of D-UVR on a three-dimensional reconstructed skin model has 
been studied. In such conditions, skin morphological alterations could only be identified afterward the 
highest dose of D-UVR. Outcomes were focused on oxidative stress induced by D-UVR. A cell type 
differential response was observed: it was more rapid in fibroblasts, with a bulk of inductions and high 
levels of modulation, in contrast to keratinocyte behavior. Results evidenced a higher sensitivity in 
response to oxidative stress in dermal fibroblasts located at the bottom of epidermal layers, giving new 
insights into the skin molecular processes happening as a consequence of daily UV exposure [172]. 
In conclusion, DNA microarrays assays have emerged as the golden technique in the overall 
analysis of gene expression, and their achievements have bettered even the most positive expectations. 
Their scopes include the understanding of molecular events associated with unhealthy epidermis and 
skin carcinogenesis. Fortunately, these findings shall lead us to the creation and improvement of 
medical therapies and resources to develop the function of healthy skin, as well as the design of new 
politics of prevention. 
6. Concluding Remarks 
As described above, the cellular response to UV radiation involves multiple and specific signal 
transduction pathways and transcription factors. Deciphering the complex interplay between signaling 
kinases and transcription factors effectors in the control of gene expression after UV radiation is 
imperative to develop novel therapeutic strategies to overcome skin damage. Progress in understanding Int. J. Mol. Sci. 2012, 13 162 
 
 
the multitude of mechanisms induced by UV-exposure could lead to the identification and potential 
development of specific inhibitors for the prevention and control of skin photoaging and carcinogenesis. 
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